DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Statement/Offer22.04.2020 / 16:46 The issuer is solely responsible for the content of this announcement. Corporate News Bad Neustadt / Saale | 22nd April 2020 RHÖN-KLINIKUM AG: Reasoned Statements by the Board of Management and the Supervisory Board Regarding the Takeover Offer by Asklepios Kliniken GmbH & Co. KGaA The Board of Management and the Supervisory Board of RHÖN-KLINIKUM Aktiengesellschaft, Bad Neustadt / Saale, have today issued separate reasoned statements regarding the voluntary public takeover offer by Asklepios Kliniken GmbH & Co. KGaA, Rübenkamp 226, 22307 Hamburg, Germany, which was published on 8th April 2020, pursuant to § 27, Subsection 1, German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz - WpÜG). Said reasoned statements are addressed to the shareholders of RHÖN-KLINIKUM Aktiengesellschaft. Copies of the reasoned statements are available free of charge since the day of publication at the headquarter of RHÖN-KLINIKUM Aktiengesellschaft, Am Schlossplatz 1, 97616 Bad Neustadt / Saale, Germany, Telephone: +49 9771 65-0, Facsimile: +49 9771 97467 (or via e-mail: ir(at)rhoen-klinikum-ag.com stating your full postal address). Furthermore the reasoned statements and the associated courtesy English translations are published on the website of RHÖN-KLINIKUM Aktiengesellschaft at www.rhoen-klinikum-ag.com under the pull-down menu "Investor Relations" | "Takeover Offer". Only the respective German version of the reasoned statement is legally valid. RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The hospital group offers excellent medical care with a direct link to universities and research institutes. Over 860,000 patients are treated every year at the five group hospitals located in Bad Berka, Bad Neustadt, Frankfurt (Oder), Giessen and Marburg where more than 18,000 employees work. RHÖN-KLINIKUM AG is currently exploiting the opportunities available to develop new areas of growth. Entering the forward-looking telemedicine market with Medgate Deutschland, the innovative RHÖN campus concept for offering avantgarde healthcare across sectoral boundaries in rural areas as well as consistently extending our gradual corporate digitalisation are key pillars of the corporate strategy. More information under www.rhoen-klinikum-ag.com Follow us www.twitter.com/rhoenklinikumag www.xing.com/companies/rhön-klinikumag www.youtube.com/rhönklinikumag
Contact Persons: RHÖN-KLINIKUM AG | Head of Corporate Communications and MarketingElke PfeiferTelephone: +49 9771 65-12110 | E-Mail: elke.pfeifer(at)rhoen-klinikum-ag.com
RHÖN-KLINIKUM AG | Head of Investor Relations and TreasuryJulian SchmittTelephone: +49 9771 65-12250 |E-Mail: julian.schmitt(at)rhoen-klinikum-ag.com RHÖN-KLINIKUM AG | Schlossplatz 1 | 97616 Bad Neustadt / Saale, Germany 22.04.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de |
| Language: | English |
| Company: | RHÖN-KLINIKUM Aktiengesellschaft |
| Salzburger Leite 1 | |
| 97616 Bad Neustadt a.d.Saale | |
| Germany | |
| Phone: | +49 (0)9771 - 65-0 |
| Fax: | +49 (0)9771 - 97 467 |
| E-mail: | rka@rhoen-klinikum-ag.com |
| Internet: | www.rhoen-klinikum-ag.com |
| ISIN: | DE0007042301 |
| WKN: | 704230 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1027505 |
| End of News | DGAP News Service |